K190542 is an FDA 510(k) clearance for the Soliton Acoustic Wave Device. Classified as Powered Laser Surgical Instrument within the GEX classification (a category for powered laser surgical instruments across multiple specialties), Class II - Special Controls.
Submitted by Soliton, Inc. (Houston, US). The FDA issued a Cleared decision on May 24, 2019 after a review of 81 days - a notably fast clearance cycle.
This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4810 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.
View all Soliton, Inc. devices
NCT03125824
Completed
Interventional
Industry-sponsored
Soliton Planar Acoustic Wave Device System for Dermal Tattoo Clearing Human Trial Protocol
Soliton Planar Acoustic Wave Device System for Dermal Tattoo Clearing Human Trial
| Condition studied |
Tattooing |
| Study design |
Single group |
| Eligibility |
All sexes
· 22 Years+
|
| Principal investigator |
Christopher Cappelli, MD |
| Sponsor |
Soliton
(industry)
|
Started 2017-02-13
→
Primary completion 2018-05-23
→
Completed 2018-09-25
Primary outcome
Tattoo clearance
Secondary outcome
Incidence of Treatment Emergent Adverse Events for Safety Reporting
Study completed - no results published.
This trial concluded in 2018 but has not posted
results to ClinicalTrials.gov. Completed studies without public results are common
in industry-sponsored device trials; the data may be referenced in the
510(k) Summary PDF or remain unpublished.
Individual participant data will not be shared.
View full study on ClinicalTrials.gov